Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer-Reference-Cited by-同舟云学术

Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer

Published:2004-04 Issue:1 Volume:44 Page:121-127
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ando Masahiro,Kobayashi Kunihiko,Yoshimura Akinobu,Kurimoto Futoshi,Seike Masahiro,Nara Michiya,Moriyama Gaku,Mizutani Hideki,Hibino Suguru,Gemma Akihiko,Okano Tetsuya,Shibuya Masahiko,Kudoh Shoji

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference18 articles.

1. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group;Saltz;N. Engl. J. Med.,2000

2. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer;Cunningham;Lancet,1998

3. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer;Rougier;Lancet,1998

4. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer;Noda;N. Engl. J. Med.,2002

5. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer;Sargent;N. Engl. J. Med.,2001

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Which chemotherapy regimen might be the best for the second-line treatment of patients with small-cell lung cancer?;Oncology in Clinical Practice;2021-12-30

2. Treatment strategy for patients with relapsed small-cell lung cancer: past, present and future;Translational Lung Cancer Research;2020-04

3. Irinotecan, topotecan, paclitaxel or docetaxel for second-line treatment of small cell lung cancer: a single-center retrospective study of efficiency comparation and prognosis analysis;Translational Lung Cancer Research;2019-12

4. A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer;Investigational New Drugs;2017-12-26

5. Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy;Medicine;2017-10